Board of directors
Meet our board of directors
Receive cybersecurity intelligence in your inbox
Subscribe to HEAL Security Dispatch, the No.1 source for healthcare cybersecurity news, perspectives and analysis.
Advanced cybersecurity intelligence and command centers; continually monitor, analyze and report on all global cyber threat and risk activity.
The company’s executive team collectively brings over 150 years of international management and entrepreneurial experience.
Stay up-to-date on how HEAL Security is revolutionizing cybersecurity for healthcare.
Advanced cybersecurity intelligence and command centers; continually monitor, analyze and report on all global cyber threat and risk activity.
The company’s executive team collectively brings over 150 years of international management and entrepreneurial experience.
Stay up-to-date on how HEAL Security is revolutionizing cybersecurity for healthcare.
Subscribe to HEAL Security Dispatch, the No.1 source for healthcare cybersecurity news, perspectives and analysis.
Solutions
HEAL Security Dispatch
HEAL Security Guardian
HEAL Security Bridge
HEAL Security Terminal
HEAL Security Console
HEAL Security Recruit
HEAL Security Team
Company
Founder, President and CEO, HEAL Security Inc.
Charles brings more than 25 years of healthcare IT and cybersecurity experience to HEAL Security. He is also Managing Director of Technology and an advisory board member of Health2047, the innovation arm of the American medical Association. Previously, he was Senior Executive Director at Stanford Clinic and SVP at Cleveland Clinic. He held prior executive positions at NHS, BUPA Healthcare, Accenture, KPMG, Microsoft and Glaxo. Charles’s entrepreneurial experience includes start-up team at ServerWare, leading a technology spinout from Schlumberger, and serving as founding CTO of VHGroup/Music 3w and Co-Founder and CTO of SDN Networking. He is an official member of the Forbes Technology Council, and an ELITE Group Executive and Distinguished Fellow by Royal Charter of the British Computer Society.
CEO, Health2047 Inc.
Larry has served as Executive Vice President of Research and Business Development at Kadmon Holdings; President and CEO of VIA Pharmaceuticals; President and CEO at Zyomyx; COO of Progenitor, Inc.; Vice President of Research of Somatix Therapy Corporation. He has a doctoral degree in Microbiology from The University of Illinois and a Postdoctoral in Molecular Biology at the Dana-Farber Cancer Institute, and the Department of Biochemistry at Harvard Medical School.